Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Drug class
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Drug class outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Colorectal Cancer Therapeutics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Colorectal Cancer Therapeutics Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic Landscape
Chapter 4. Colorectal Cancer Therapeutics Market: Drug Class Estimates & Trend Analysis
4.1. Colorectal Cancer Therapeutics Market: Key Takeaways
4.2. Colorectal Cancer Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Chemotherapy
4.3.1. Chemotherapy market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Immunotherapy
4.4.1. Immunotherapy market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Others
4.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Colorectal Cancer Therapeutics Market: Regional Estimates & Trend Analysis
5.1. Regional Outlook
5.2. Colorectal Cancer Therapeutics Market by Region: Key Takeaway
5.3. North America
5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.3.2. U.S.
5.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.3.3. Canada
5.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.4. Europe
5.4.1. UK
5.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.4.2. Germany
5.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.4.3. France
5.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.4.4. Italy
5.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.4.5. Spain
5.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.4.6. Denmark
5.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.4.7. Sweden
5.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.4.8. Norway
5.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.5. Asia Pacific
5.5.1. Japan
5.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.5.2. China
5.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.5.3. India
5.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.5.4. Australia
5.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.5.5. Thailand
5.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.5.6. South Korea
5.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.6. Latin America
5.6.1. Brazil
5.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.6.2. Mexico
5.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.6.3. Argentina
5.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.7. MEA
5.7.1. South Africa
5.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.7.2. Saudi Arabia
5.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.7.3. UAE
5.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.7.4. Kuwait
5.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Market Participant Categorization
6.2.1. Amgen, Inc.
6.2.1.1. Company Overview
6.2.1.2. Financial performance
6.2.1.3. Product benchmarking
6.2.1.4. Strategic initiatives
6.2.2. Bayer AG
6.2.2.1. Company overview
6.2.2.2. Financial performance
6.2.2.3. Product benchmarking
6.2.2.4. Strategic initiatives
6.2.3. Bristol-Myers Squibb Company
6.2.3.1. Company overview
6.2.3.2. Financial performance
6.2.3.3. Product benchmarking
6.2.3.4. Strategic initiatives
6.2.4. Lilly
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. Merck & co., Inc.
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. F. Hoffmann-La Roche Ltd
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. Sanofi
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
Table 1 List of Abbreviations
Table 2 North America colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 3 North America colorectal cancer therapeutics market, by region, 2018 - 2030 (USD Million)
Table 4 U.S. colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 5 Canada colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 6 Europe colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 7 Europe colorectal cancer therapeutics market, by region, 2018 - 2030 (USD Million)
Table 8 Germany colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 9 UK colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 10 France colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 11 Italy colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 12 Spain colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 13 Sweden colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 14 Norway colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 15 Denmark colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 16 Asia Pacific colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 17 Asia Pacific colorectal cancer therapeutics market, by region, 2018 - 2030 (USD Million)
Table 18 Japan colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 19 China colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 20 India colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 21 Australia colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 22 Thailand colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 23 South Korea colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 24 Latin America colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 25 Latin America colorectal cancer therapeutics market, by region, 2018 - 2030 (USD Million)
Table 26 Brazil colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 27 Mexico colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 28 Argentina colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 29 Middle East and Africa colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 30 Middle East and Africa colorectal cancer therapeutics market, by region, 2018 - 2030 (USD Million)
Table 31 South Africa colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 32 Saudi Arabia colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 33 UAE colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 34 Kuwait colorectal cancer therapeutics market, by drug class, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Colorectal cancer therapeutics: Market outlook
Fig. 9 Colorectal cancer therapeutics: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Colorectal cancer therapeutics market driver impact
Fig. 15 Colorectal cancer therapeutics market restraint impact
Fig. 16 Colorectal cancer Therapeutics market strategic Initiatives analysis
Fig. 17 Colorectal cancer therapeutics market: Drug class movement analysis
Fig. 18 Colorectal cancer therapeutics market: Drug class outlook and key takeaways
Fig. 19 Immunotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Chemotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Other market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Global Colorectal Cancer Therapeutics market: Regional Movement Analysis
Fig. 23 Global Colorectal cancer therapeutics market: Regional outlook and key takeaways
Fig. 24 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
